CELZ — CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1187953 ·
Last close
$1.03
Market Cap
$6.79M
52W High
$6.25
52W Low
$0.62
ADV30
1,307,453
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | 0 | -1,562,163 | -1,511,976 | 9,377,653 | 8,714,115 | 698,595 |
| Mar 2026 | 0 | 0 | -1,459,153 | -1,405,077 | 6,440,577 | 5,723,176 | 307,649 |
| Dec 2025 | 3,000 | 2,006 | -1,945,782 | -1,887,674 | 7,809,525 | 7,208,126 | 284,880 |
| Sep 2025 | 0 | 0 | -1,273,034 | -1,235,934 | 5,853,003 | 5,375,511 | 261,353 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,588,220
Investing CF
$-225,500
Financing CF
$3,834,029
CapEx
$-125,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-2.17
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-71,991,998
Inventory
$0
Receivables
$105,711
ST Investments
$125,000
EBIT TTM
$-5,941,489
Pretax Income TTM
$-5,760,628
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,000
EBITDA
$-6,126,351
Free Cash Flow
$-3,456,562
Enterprise Value
$-2,468,024
Total Cash
$8,839,115
Total Debt
$14,194
Shares Out
6,592,557
Trailing EPS
$-2.05
Book Value
$1.33
ROE
-77.9%
ROA
-47.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 6,000 | -6,142,814 | -5,995,008 | 7,809,525 | 284,880 | 7,514,645 | -5,856,445 |
| Dec 2024 | 11,000 | -5,743,861 | -5,493,481 | 6,669,143 | 327,644 | 6,341,499 | -5,301,292 |
| Dec 2023 | 9,000 | -5,620,132 | -5,286,574 | 10,715,190 | 371,394 | 10,343,796 | -8,027,885 |
| Dec 2022 | 88,600 | -10,244,372 | -10,144,044 | 19,186,326 | 3,321,652 | 15,864,674 | -7,796,966 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.88
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AIM | AIM ImmunoTech Inc. | $7.11M | $0.19 | — |
| LIMN | Liminatus Pharma, Inc. | $5.63M | $4.20 | — |
| CUBT | Curative Biotechnology Inc | $8.89M | $1.00 | — |
| PMCB | PharmaCyte Biotech, Inc. | $4.73M | $0.44 | — |
| SNTI | Senti Biosciences Holdings, Inc. | $10.25M | $0.33 | — |
News headlines (Yahoo Finance, 1h cache)
Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing
2026-09-17 13:00 · Yahoo
Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluat
2026-08-20 13:15 · Yahoo
Creative Medical Receives U.S. Patent Allowance for Exosome-Based Type 1 Diabetes Immunotherapy
2026-08-06 15:04 · Yahoo
Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CEL
2026-08-06 13:15 · Yahoo
Creative Medical Technology Holdings Issues Mid-Year Update
2026-07-01 13:00 · Yahoo
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
2026-06-30 18:07 · Yahoo
These Three Stocks Fell More Than 10% Today To Hit 52-Week Lows -- What's Driving The Investor Skepticism?
2026-06-26 17:54 · Yahoo
Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain
2026-06-22 13:15 · Yahoo
Creative Medical Technology opens nationwide burn-pit data registry
2026-06-16 19:49 · Yahoo
Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards
2026-06-16 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.